We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Novartis Adds Two Bispecific Antibodies to its Development Portfolio

News   Jun 29, 2016

 
Novartis Adds Two Bispecific Antibodies to its Development Portfolio
 
 
 

RELATED ARTICLES

Being Organized Maintains Immune Heath

News

Immune health is maintained by the exquisite organisation skills of a protein called Pax5.

READ MORE

What Pneumococcus Says to Make You Sick

News

This study of "bacterial linguistics," attempts to identify the "words" that bacteria use to communicate.

READ MORE

3-in-1 Vaccine Against Traveller’s Diarrhea

News

Conjugate vaccines could be a platform for a multi-pathogen, multi-serotype vaccine against the three major causes of diarrheal disease worldwide.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE